Metabolomics as a tool for drug discovery and personalised medicine. A review.
Curr Top Med Chem
; 14(23): 2627-36, 2014.
Article
em En
| MEDLINE
| ID: mdl-25515755
ABSTRACT
Studying the effects of drugs on the metabolome constitutes a huge part of the metabolomics discipline. Whether the approach is associated with drug discovery (altered pathways due to the disease that provide future targets and information into the mechanism of action or resistance, etc.) or pharmacometabolomics (studying the outcome of treatment), there have been many aspiring published articles in this area. With specific experimental design, including fingerprinting analysis with different analytical platforms in a non-targeted way, the approach is advancing towards the discovery of markers for the implication of personalised medicine, while also providing information that could help to improve the efficacy and reduce the side effects associated with a treatment. In this review, the evolution of pharmacometabolomics from other areas of drug efficacy metabolomics studies is explored.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Drogas em Investigação
/
Doenças Neurodegenerativas
/
Metaboloma
/
Metabolômica
/
Doenças Metabólicas
/
Neoplasias
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article